Tous Actualités
Suivre
Abonner november AG

november AG

euro adhoc: november AG
Mergers - Acquisitions - Takeovers
november AG assigns peqlab

  Disclosure announcement transmitted by euro adhoc. The issuer is responsible
  for the content of this announcement.
Company Information
23.04.2008
Erlangen, 23rd April 2008. With approval of the Supervisory Board 
november AG assigns its 51% share of PELAB Biotechnologie GmbH with 
immediate effect. The compensation of EUR 1,500,000.00 will be 
payable by instalments.
end of announcement                               euro adhoc

Further inquiry note:

Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN: DE000A0S9N72
WKN: A0S9N7
Index: CDAX, Prime All Share, Technologie All Share
Börsen: Börse Frankfurt / regulated dealing/prime standard
Börse Berlin / free trade
Börse Stuttgart / free trade
Börse Düsseldorf / free trade
Börse Hannover / free trade
Börse München / free trade

Plus de actualités: november AG
Plus de actualités: november AG